Tudor Investment Corp’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,289
Closed -$139K 1620
2020
Q2
$139K Sell
10,289
-22,680
-69% -$264K 0.01% 1065
2020
Q1
$391K Sell
32,969
-32,676
-50% -$724K 0.04% 591
2019
Q4
$1.64M Buy
65,645
+40,257
+159% +$816K 0.07% 352
2019
Q3
$432K Buy
+25,388
New +$462K 0.01% 756
2019
Q2
Sell
-37,365
Closed -$1.2M 1414
2019
Q1
$1.2M Buy
37,365
+7,581
+25% +$235K 0.05% 414
2018
Q4
$839K Buy
29,784
+10,473
+54% +$307K 0.02% 447
2018
Q3
$555K Sell
19,311
-5,753
-23% -$173K 0.01% 657
2018
Q2
$939K Buy
25,064
+2,423
+11% +$95.1K 0.03% 457
2018
Q1
$890K Buy
22,641
+562
+3% +$20.5K 0.03% 359
2017
Q4
$715K Buy
22,079
+6,640
+43% +$199K 0.02% 460
2017
Q3
$481K Buy
+15,439
New +$457K 0.01% 654
2015
Q3
Sell
-16,771
Closed -$480K 1814
2015
Q2
$480K Buy
+16,771
New +$440K 0.01% 803

Other funds holding XENT

Tudor Investment Corp's XENT Position: Q3 2020 in Review

Tudor Investment Corp sold out of Intersect ENT, Inc (XENT) in Q3 2020, closing a stake of 10,289 shares — an estimated $139K sold.

Tudor Investment Corp first reported a position in XENT in Q2 2015 and held it in 12 quarters. The position peaked at $1.64M in Q4 2019. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2020.

  • Tudor Investment Corp reported no remaining Intersect ENT, Inc position as of Q3 2020 after selling out during the quarter.
  • Tudor Investment Corp sold 10,289 Intersect ENT, Inc shares in Q3 2020, an estimated $139K.
  • Tudor Investment Corp first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 12 quarters.
  • Tudor Investment Corp's Intersect ENT, Inc position peaked at $1.64M in Q4 2019.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2020.

Based on Tudor Investment Corp's 13F filing for Q3 2020, filed 16 Nov 2020.